Safety and efficacy of peptide receptor radionuclide therapy with <sup>177</sup>Lu-DOTA<sup>0</sup>-Tyr<sup>3</sup>-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors.

Authors:
Kobayashi N; Takano S; Ito K; Sugiura M; Ogawa M and 11 more

Journal:
Ann Nucl Med

Publication Year: 2021

DOI:
10.1007/s12149-021-01674-9

PMCID:
PMC8557155

PMID:
34533700

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ann Nucl Med

Abbreviation: Ann Nucl Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nuclear Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Role of PET/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review.
Singh SB; Bhandari S; Bhandari S and 7 more (2024) - Transparency Score: 3/6
Effect of scan-time shortening on the <sup>11</sup>C-PHNO binding potential to dopamine D<sub>3</su…
Matsunaga K; Tonomura M; Abe K and 1 more (2023) - Transparency Score: 3/6
High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early s…
Makino A; Kume K; Mori T and 4 more (2023) - Transparency Score: 3/6
Practice recommendation for measuring washout rates in <sup>123</sup>I-BMIPP fatty acid images.
Nakajima K; Miyauchi H; Hirano KI and 4 more (2023) - Transparency Score: 3/6
Quantitative comparative analysis of amyloid PET images using three radiopharmaceuticals.
Jeong YJ; Yoon HJ; Kang DY and 1 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
0/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025